(Q81470399)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

main subject

Streptococcus pneumoniae

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ken Beagley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Peter G Gibson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Ama-Tawiah Essilfie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jay C Horvat

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Margaret A Wade

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Paul S Foster

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Philip M Hansbro

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

4 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

8154-8162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

Asthma: an epidemic of dysregulated immunity

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Bacterial DNA causes septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Treatment of steroid-dependent asthma with recombinant interferon-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophilia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Asthma as a risk factor for invasive pneumococcal disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Genetic background affects susceptibility in nonfatal pneumococcal bronchopneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Reduction by cefodizime of the pulmonary inflammatory response induced by heat-killed Streptococcus pneumoniae in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Functional diversity of helper T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Vaccination with heat-killed Listeria as adjuvant reverses established allergen-induced airway hyperreactivity and inflammation: role of CD8+ T cells and IL-18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Peripheral blood CD4+ and CD8+ T cell type 1 and type 2 cytokine production in atopic asthmatic and normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Effects of anticytokine therapy in a mouse model of chronic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Eosinophilic Inflammation in Asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

A critical role for eosinophils in allergic airways remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Recombinant human interleukin 5 is a selective activator of human eosinophil function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Interleukin-5 and eosinophils as therapeutic targets for asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Immunoglobulins and immunogenicity of pneumococcal vaccination in preschool asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

Prophylaxis of otitis media in asthmatic children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.09.034

10.1016/J.VACCINE.2007.09.034

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17950502%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference